A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
LEMP
En personas con SIDA, el tratamiento para fortalecer el sistema inmunitario puede llevar a la recuperación de los síntomas de la leucoencefalopatía multifocal progresiva. No se ha demostrado la efectividad de otros tratamientos para esta enfermedad.
La leucoencefalopatía multifocal progresiva es una afección potencialmente mortal. Hable con el médico acerca de las decisiones sobre los cuidados.
Boren EJ, Cheema GS, et al. The emergence of progressive multifocal leukoencephaloparhy (PML) in rheumatic diseases. J Autoimmun. 2008;30(1-2):90-98.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885